Houston, TX -- (SBWIRE) -- 01/24/2018 -- Yellow fever is an acute viral fever caused by a mosquito-borne flavivirus. Most of these infections are asymptomatic. In those individuals who develop the condition, the clinical spectrum ranges from nonspecific flu-like illness with fever, malaise, prostration, headache, photophobia, generalized arthralgia and myalgia, nausea, and/or vomiting to potentially lethal pan systemic disease, most prominently involving the liver, kidneys, GI tract, and brain, with recrudescing fever, jaundice, renal failure, severe hemorrhage due to thrombocytopenia, and shock. The case mortality rate of yellow fever varies extensively in different studies but is typically 20% or higher. Jaundice or other gross evidence of severe liver disease is associated with higher mortality rates. In terms of revenue, the Global Yellow Fever Vaccine Market was valued at US$ 56.63 Mn in 2016 and is expected to reach US$ 81.75 Mn by 2025, expanding at a CAGR of 4.3% from 2017 to 2025.

For Sample Copy of this report: https://www.researchnreports.com/request_sample.php?id=186116

The Global Yellow Fever Vaccine Market is enhanced by factors such as:

Growing consciousness among people pertaining to the availability of treatment to cure yellow fever.

Growing number of international travelers.

Based on applications, the Global Yellow Fever Vaccine Market is segmented into routine immunization, preventative campaigns and outbreak response. Out of these, the preventative campaigns segment dominated the global market in the preceding years and it is anticipated to endure its dominance in the future as well. These campaigns have been crucial to stopping the spread of the outbreak. The preventive vaccination campaign aims to build protection in the population perceived to be at high risk of getting infected and prevent potential spread and expansion of the current outbreak.

Now Avail Discount on this report at https://www.researchnreports.com/ask_for_discount.php?id=186116

The Global Yellow Fever Vaccine Market has been segmented into five major regions, namely North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa. Among these regions, Middle East & Africa is estimated to be the dominant market. It accounted for the largest market share in 2016, and is expected to expand at the highest CAGR over the forecast period. Increasing awareness in people towards the use of new technologies is driving the growth of the Global Yellow Fever Vaccine Market.

For more information https://www.researchnreports.com/enquiry_before_buying.php?id=186116

The report also includes a thorough overview of the competitive landscape and regulatory framework of the Global Yellow Fever Vaccine Market. This helps readers with a clear understanding of the state of competition, threats, major opportunities, and the major rules, regulations, plans, and policies impacting the market. The report serves as a helpful guide for the new as well as existing players in the market. Some of the significant players functional in the Global Market include Sanofi Pasteur, Bio-Manguinhos, FSUE Chumakov, Institut Pasteur de Dakar and so on. Few of the other prominent players are Themis Bioscience GmbH, Arbovax Inc., Institute of Poliomyelitis and Viral Encephalitides and Berna Biotech Ltd among others.